Navigation Links
Reducing Corticosteriod Use In Asthmatics

According to a recent study researchers say, Montelukast, a leukotriene-receptor antagonist (leukotrienes mediate inflammation // in the body and play a role in allergic reactions), decreased incidents of asthma in young children by about 32 percent while also reducing corticosteroid use .

Researchers conducted a one-year study involving 549 children from 68 sites in 23 countries. In the study, 278 of the children received low-dose montelukast once a day for 12 months while 271 of the children received a placebo. Results showed exacerbation of asthma occurred 1.6 times per patient per year in those taking montelukast compared with 2.24 incidents per patient per year in the placebo group.The study also showed an overall corticosteroid use was cut by 32 percent in those who took Montelukast, and inhaled corticosteroid use decreased by 40 percent.

In conclusion researchers say, that montelukast shouldn't be used the whole year round instead, the medication should be reserved more for seasonal use .
'"/>




Page: 1

Related medicine news :

1. Reducing Lung Cancer Risk
2. Reducing the risk for type 2 diabetes
3. Reducing Medication Errors
4. Reducing HIV Transmission
5. Reducing Pain from Knee Surgery
6. Reducing Pain From Knee Surgery
7. Reducing The After Effects of Tonsillectomy
8. Antiparasitic Drug Effective In Reducing Seizures In Neurocysticercosis Patients
9. Reducing Number Of Cigarettes Not Enough
10. Drug Found Effective In Reducing Vertebral Fractures In Women
11. Reducing TB With Ultraviolet Light
Post Your Comments:
Breaking Medicine Technology:New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite 2Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite 3Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite 4Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite 5Biophysical Society names 2010 award recipients 9795 1Biophysical Society names 2010 award recipients 9795 2Anthem Life 26 Disability Insurance Company Offers The Healing Book to Help Young Life Insurance Beneficiaries Cope With Losing a Loved One 56277 1Anthem Life 26 Disability Insurance Company Offers The Healing Book to Help Young Life Insurance Beneficiaries Cope With Losing a Loved One 56277 2TOMORROW 3A Lets Get It Done 3A Organizing for America to Host Spanish Language Forum on Health Insurance Reform Now in Tucson with Rep Raul Grijalva 56274 1TOMORROW 3A Lets Get It Done 3A Organizing for America to Host Spanish Language Forum on Health Insurance Reform Now in Tucson with Rep Raul Grijalva 56274 2